Medicare Part D Deductible to $2,000 Cap in 2026: What Eliquis and Januvia Actually Cost You Before the Coverage Gap Closes
Your pharmacist rings up your Eliquis refill in January and it's $590 — not the $47 copay you paid every month last year. You didn't do anything wrong. You just hit the Part D deductible reset that happens every January 1st, and if you're also filling Januvia or another Tier 3 brand-name drug, you're about to spend the next several months watching that number swing around before it settles into something predictable.
I've sat across the table with enough people at the senior center to know this catches almost everyone off guard, even folks who've been on Medicare for a decade. The good news: the redesigned Part D benefit that took effect in 2025 and carries into 2026 actually caps your annual drug spending at $2,000. The less good news: how fast you get there — and what plan you picked back in October — determines whether that $2,000 costs you $2,300 total or $3,100 total once you add in premiums. That's the number worth checking before you assume your current plan is still the right one.
How the 2026 Part D Benefit Actually Works
Every standalone Part D plan and every Medicare Advantage plan with drug coverage (MAPD) follows the same federal structure now, even though the premiums and formulary tiers differ wildly:
- Deductible phase — You pay 100% of drug costs up to the plan's deductible (up to $590 in 2026, though some plans set it lower or waive it on preferred generics).
- Initial coverage phase — You pay 25% coinsurance on covered drugs; the plan and manufacturer cover the rest.
- Catastrophic phase — Once your true out-of-pocket spending (deductible + coinsurance, not the insurer's contribution) hits $2,000, you pay $0 for the rest of the calendar year.
That $2,000 cap is the headline change from the Inflation Reduction Act, and it replaced the old "donut hole" system where people fell into a coverage gap and paid 25-40% of costs with no ceiling until they reached catastrophic coverage — sometimes not until October. I've written before about how this redesign interacts with the $2,000 out-of-pocket cap and rising Medicare Advantage overpayment risk for 2027 premiums, and it's worth revisiting because the mechanics of how you get to $2,000 still vary enormously by plan.
The Worked Example: Eliquis + Januvia
Let's run actual numbers. Say you take Eliquis (a Tier 3 brand blood thinner, negotiated plan price roughly $560/month) and Januvia (a Tier 3 brand diabetes drug, negotiated plan price roughly $580/month) — a combined negotiated drug cost of about $1,140/month, or roughly $900/month once you account for typical plan-negotiated discounts that don't always match retail list price.
January: You pay the full $590 deductible on your first fill. That alone nearly exhausts one month's drug cost.
February through mid-summer: You move into the 25% coinsurance phase. You need $1,410 more in out-of-pocket coinsurance payments to reach the $2,000 cap ($2,000 minus the $590 deductible already paid). At 25% coinsurance, that requires roughly $5,640 in negotiated drug costs to pass through the plan.
At approximately $900/month in negotiated drug spending, that's about 6.3 months — meaning most people on this exact combination hit the $2,000 cap around July, not December.
August through December: $0 cost-sharing on Eliquis, Januvia, and every other covered drug on the formulary for the rest of the year.
Total annual drug cost: $2,000, no matter which Part D plan you're enrolled in, because the cap is federally mandated across all plans. This is the part almost nobody realizes: once you know you're a lock to hit the cap, your copay structure stops mattering and your premium becomes the only variable left to compare.
Why the Premium Is the Only Number That Matters — If You'll Hit the Cap
Here's where plan selection actually saves or costs you real money. Based on Toravine's analysis of the cms_medicare_plan_premiums dataset (1,236 rows tracking plan-level premium data), standalone Part D premiums for 2026 in a typical state range from roughly $28/month to $82/month for plans covering the same formulary tier structure.
| Plan type | Monthly premium | Annual premium | Drug cost (capped) | Total annual cost |
|---|---|---|---|---|
| Low-premium standalone PDP | $34/mo | $408 | $2,000 | $2,408 |
| Mid-tier standalone PDP | $55/mo | $660 | $2,000 | $2,660 |
| Enhanced PDP (lower initial copays) | $79/mo | $948 | $2,000 | $2,948 |
| $0-premium MAPD (bundled) | $0/mo | $0 | $2,000 | $2,000 |
Same drugs. Same $2,000 out-of-pocket ceiling. A $540 swing in total annual cost based purely on which plan you picked during open enrollment — and the "enhanced" plan with lower up-front copays, which sounds better on paper, is actually the worst deal once you know you'll blow through the deductible and coinsurance phase in a matter of months anyway.
The $0-premium MAPD option looks cheapest on this table, but it comes with a catch worth flagging honestly: Medicare Advantage plans layer in prior authorization requirements that standalone PDPs paired with Original Medicare typically don't apply to Part D drugs the same way. I've covered how prior authorization denials on Medicare Advantage formularies can add $2,400 or more when a drug's tier placement changes mid-year, and that risk doesn't show up in a premium comparison table. This is the kind of analysis Toravine runs for you — cross-referencing premium data against formulary tier placement and prior auth flags — so you don't have to build the spreadsheet yourself every October.
The Hidden IRMAA Trap: How Your Savings Account Interest Feeds Into This
Here's a connection most people miss entirely. NerdWallet's recent piece on how CD and savings account interest is taxed makes a simple point: interest income is taxed at your regular income tax rate, and it counts as income the year it's earned — not the year you withdraw it. What that article doesn't connect, but what matters enormously for Medicare beneficiaries, is that this same interest income counts toward your Modified Adjusted Gross Income (MAGI), which is exactly what determines your IRMAA bracket two years later.
Based on Toravine's review of the cms_medicare_irmaa dataset (174 rows tracking income-related surcharge tiers), a single filer with MAGI in the roughly $106,000–$133,000 range in 2026 pays an estimated Part D IRMAA surcharge of around $13.70/month on top of whatever premium is listed above — and that's stacked on a similar Part B surcharge. If you've built up a CD ladder or high-yield savings account for medical emergencies (a smart move, and one NerdWallet's savings rate explainer encourages), the interest that account throws off in a strong rate year can be exactly the amount that tips your MAGI over an IRMAA threshold. You end up paying more in Part D surcharges specifically because you saved responsibly for the $2,000 out-of-pocket cap you'll owe anyway.
This is a two-year-lag trap: 2026 IRMAA brackets are based on your 2024 tax return. If interest rates were elevated in 2024 and your CD or savings balance threw off more taxable income than usual, you may be sitting in a higher IRMAA bracket right now than your current income would suggest — and it won't reset until your 2025 or 2026 return works through the system. Toravine's census_acs_medicare dataset (6,287 rows of beneficiary income and demographic data by region) shows a meaningful share of Medicare households sit within a few thousand dollars of an IRMAA cliff, which means modest interest income swings genuinely move people across brackets. You can model this against your specific accounts and income at Toravine.
Why Premiums Keep Drifting Upward Industry-Wide
It's worth understanding the broader cost pressure behind these premium tables, even briefly. Healthcare Dive reported that lawmakers are moving to subpoena Oracle executives over EHR project costs that nearly tripled the contract ceiling on a VA electronic health records deployment — a reminder that administrative and technology overhead in the healthcare system is a real, escalating line item that eventually shows up somewhere in premium and cost structures across the system. Separately, the completed acquisition of Fairfield Medical Center by Adena Health, following federal antitrust scrutiny, is part of a broader wave of hospital consolidation that reshapes which health systems negotiate drug and network contracts in a given region — directly affecting what "in-network" pricing looks like on your Medicare Advantage plan if your local hospital changes hands. Neither story is about Part D directly, but both explain why the plan comparison you ran two years ago is worth re-running now rather than assuming nothing changed.
What to Actually Check Before You Assume Your Plan Is Still Right
If you're on one or more brand-name maintenance drugs, walk through three things before the next enrollment window:
- Will you hit the $2,000 cap this year? If yes, stop comparing copay structures and just compare premiums plus deductible timing — the plan with the lowest premium and fastest deductible clearing usually wins.
- Is your MAGI close to an IRMAA threshold? Check your last two tax returns, including any CD or savings interest, before assuming your surcharge tier is stable.
- Did your formulary tier placement change? Plans revise formularies every January, and a drug moving from Tier 2 to Tier 3 can undo all the premium savings you calculated above.
None of this is a one-time decision. Every open enrollment window is a fresh comparison, and the 10-year cost of staying on autopilot compounds the same way a late enrollment penalty does — quietly, and permanently, unless you check. You can run your specific drug list, premium options, and income situation against current formulary and IRMAA data at Toravine before your next enrollment deadline.
Sources
- Lawmakers to subpoena Oracle execs as EHR project costs rise — Healthcare Dive
- Adena Health acquires Fairfield Medical Center after antitrust scrutiny — Healthcare Dive
- Interest on CDs and Savings Accounts is Taxable. Here’s What To Know — NerdWallet
- What Is a Savings Rate? How to Find Yours and Why It Matters — NerdWallet
- Mortgage Rates Today, Friday, September 4: A Little Lower — NerdWallet